IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies

Cancer Clinical Trial Compensation: Undue or Long Overdue?

Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials

More Than a Partnership: How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive Research

Veterans Health Administration’s Lung Precision Oncology Program Helps Individualize Treatment

Awareness-raising Bike Ride in The Netherlands Connected Hospitals, Patients

Survivorship in Lung Cancer: An Interview With Dr. Anne Katz

Lung Cancer Health Care Delivery, Community Building, and Research: Are They Truly Inclusive?

Ending Stigma in Lung Cancer: The IASLC Participates in a Collaborative Summit Held by the National Lung Cancer Roundtable 

Disrupting the Paradigm: Partnering With Oncogene-Focused Patient Groups to Propel Research

A Balancing Act: Managing Patients’ Expectations

STARS Patient Research Advocate Training Program Seeks Patients and Caregivers